Healthcare Distribution Market

Detailed market report on the healthcare distribution market, including industry analysis, size, and forecast trends from 2025 to 2030.

The Report Covers Global Healthcare Distribution Market Distributors and it is Segmented by Product Type (Pharmaceutical Product Distribution Services (Over the Counter Drugs, Generic Drugs, and Branded Drugs), Biopharmaceutical Product Distribution Services (Recombinant Proteins, Monoclonal Antibodies, and Vaccines), and Medical Devices Distribution Services), End-User (Retail Pharmacies, Hospital Pharmacies, and Other End-users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Healthcare Distribution Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Healthcare Distribution Market Size

Healthcare Distribution Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 6.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Healthcare Distribution Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Healthcare Distribution Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Healthcare Distribution Market Analysis

The Healthcare Distribution Market is expected to register a CAGR of 6.5% during the forecast period.

The COVID-19 pandemic was an incomparable global public health emergency. It impacted almost every industry sector, including healthcare distribution, mainly due to disruptions to the healthcare supply chain. However, the companies took various actions to manage these disruptions in the supply chain through their strategic partners and manufacturer suppliers. For instance, as per the report published by Cardinal Health in December 2021, the company worked closely with its manufacturer suppliers to help ensure a healthy supply of products. In addition, as per the same source, the company installed a new warehouse management system in many distribution centers to manage the challenges in the healthcare supply chain. As a result, the market originally had a modest negative impact but is anticipated to develop due to corporate strategies for addressing supply chain difficulties over the coming years.

With the large economic burden of chronic diseases, technological advancement in distribution, favorable R&D investment scenario, and subsequent increase in drug launches are the main driving factors of the healthcare distribution market. For instance, in 2022, the National Institution of Chronic Disease and Data reported that nearly 60% of American adults suffer from at least one chronic disease, and about 40% of adults include multiple chronic conditions (MCC). Chronic conditions like diabetes, cancer, and cardiovascular disease are the leading causes of morbidity in the United States. Hence, proper management and diagnosis of these diseases are needed with various healthcare products necessary for effective healthcare distribution services. Thus, increasing cases of chronic disease are driving the healthcare distribution market.

Technological advancements and new distribution strategies of market players are expected to boost the healthcare distribution market. For instance, in May 2022, Nippon Express Co., Ltd. launched a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry. With this, the company provided a pharmaceutical distribution platform with strict temperatures. Hence, these new platforms in healthcare distribution are expected to hold significant growth in the market over the forecast period.

However, the high cost and investment associated with healthcare distribution services are expected to hamper the overall growth of this market.

Healthcare Distribution Industry Overview

The healthcare distribution market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known as McKesson Corporation, Cardinal Health, Morris and Dickson Company, Smith Drug Company, Owens and Minor Inc., Patterson Companies, PHOENIX Group, Owens, Medline Industries, and other Companies.

Healthcare Distribution Market Leaders

  1. McKesson Corporation

  2. Smith Drug Company

  3. Morris and Dickson Company

  4. Owens and Minor Inc

  5. PHOENIX Group

  6. *Disclaimer: Major Players sorted in no particular order
Healthcare Distribution Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Healthcare Distribution Market News

  • January 2023: Amylyx Pharmaceuticals, Inc. entered into an exclusive license and distribution agreement with Neopharm. Here, Neopharm will commercialize, subject to regulatory review and approval, AMX0035 (sodium phenylbutyrate and ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS) in Israel, Gaza, West Bank, and the Palestinian Authority.
  • May 2022: AAH Pharmaceuticals, one of the market players in the wholesale distribution of medicines in the United Kingdom, partnered with RELEX Solutions. AAH Pharmaceuticals uses RELEX to manage their forecasting and replenishment with over 1,000 vendors, support demand and supply planning across multiple product categories and characteristics such as seasonality and promotional activity, and improve efficiency through delivery flow smoothing.

Healthcare Distribution Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence and Large Economic Burden of Chronic Diseases
    • 4.2.2 Technological Advancement in Distribution
    • 4.2.3 Favorable R&D Investment Scenario, and Subsequent Increase in Drug Launches
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Healthcare Distribution
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Pharmaceutical Product Distribution Services
    • 5.1.1.1 Over The Counter Drugs
    • 5.1.1.2 Generic Drugs
    • 5.1.1.3 Branded Drugs
    • 5.1.2 Biopharmaceutical Product Distribution Service
    • 5.1.2.1 Recombinant Proteins
    • 5.1.2.2 Monoclonal Antibodies
    • 5.1.2.3 Vaccines
    • 5.1.3 Medical Devices Distribution Services
  • 5.2 By End-User
    • 5.2.1 Retail Pharmacies
    • 5.2.2 Hospital Pharmacies
    • 5.2.3 Other End-Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 McKesson Corporation
    • 6.1.2 Cardinal Health
    • 6.1.3 Morris and Dickson Company
    • 6.1.4 Smith Drug Company
    • 6.1.5 Owens and Minor Inc
    • 6.1.6 Patterson Companies
    • 6.1.7 PHOENIX Group
    • 6.1.8 Shanghai Pharmaceutical Group
    • 6.1.9 Medline Industries
    • 6.1.10 CuraScript SD
    • 6.1.11 Mutual Drug
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Healthcare Distribution Industry Segmentation

As per the scope of the market, healthcare distribution refers to entire distribution practices in the healthcare sector used for enterprise resource planning, customer relationship management, medical and pharmacy supplies, wholesaling medications, and distribution and associated services. The healthcare distribution market is segmented by product type (pharmaceutical product distribution services (over-the-counter drugs, generic drugs, and branded drugs), biopharmaceutical product distribution services (recombinant proteins, monoclonal antibodies, and vaccines), and medical devices distribution services), end-user (retail pharmacies, hospital pharmacies, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product Type Pharmaceutical Product Distribution Services Over The Counter Drugs
Generic Drugs
Branded Drugs
Biopharmaceutical Product Distribution Service Recombinant Proteins
Monoclonal Antibodies
Vaccines
Medical Devices Distribution Services
By End-User Retail Pharmacies
Hospital Pharmacies
Other End-Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Healthcare Distribution Market Research FAQs

What is the current Global Healthcare Distribution Market size?

The Global Healthcare Distribution Market is projected to register a CAGR of 6.5% during the forecast period (2025-2030)

Who are the key players in Global Healthcare Distribution Market?

McKesson Corporation, Smith Drug Company, Morris and Dickson Company, Owens and Minor Inc and PHOENIX Group are the major companies operating in the Global Healthcare Distribution Market.

Which is the fastest growing region in Global Healthcare Distribution Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Healthcare Distribution Market?

In 2025, the North America accounts for the largest market share in Global Healthcare Distribution Market.

What years does this Global Healthcare Distribution Market cover?

The report covers the Global Healthcare Distribution Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Healthcare Distribution Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Healthcare Distribution Industry Report

The Global Healthcare Distribution Market is segmented by product type, end-user, and geography. The product types include pharmaceutical product distribution services such as over the counter drugs, generic drugs, and branded drugs; biopharmaceutical product distribution services like recombinant proteins, monoclonal antibodies, and vaccines; and medical devices distribution services. The end-users are retail pharmacies, hospital pharmacies, and other end-users. The geographical segmentation covers North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

The industry report provides an in-depth industry analysis and market forecast for the healthcare distribution market. It includes valuable industry information, industry outlook, and industry trends that are crucial for understanding the market dynamics. The report also highlights the market growth and market segmentation, giving a comprehensive market overview and market review.

The market data and market predictions are essential for stakeholders to gauge the market value and market outlook. The industry statistics and industry size are detailed, offering insights into the market leaders and market growth. The report example and report pdf provide a snapshot of the research companies involved in the study.

Overall, the industry research and industry reports offer a detailed examination of the healthcare distribution market, including market forecast, market segmentation, and market value. The report covers all aspects of the market, ensuring that the industry sales and market trends are well-documented. The market outlook and market overview are essential for understanding the future direction of the healthcare distribution market.